PAR 1.96% 26.0¢ paradigm biopharmaceuticals limited..

share price

  1. 47 Posts.
    Normal for newly listed stock to hover around issue price when it is a low cap raiser as there is not much publicity associated with float .

    But once the public wakes up to who the management are and what the company has then it will wake up .

    Messsrs Rennie CEO and Kaufman MD are from Mesoblast and CSL respectively both holding important positions at their prior work .
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.